Skip to main content

B&W Tek unveils newly updated QTRam & BWAnalyst software

The QTRam is a portable Transmission Raman Spectrometer powered by our patented STRaman technology optimized for rapid and nondestructive quantitative analysis ideal for content uniformity testing of finished products such as tablets and capsules.

The updated QTRam is a compact, portable transmission Raman for content uniformity testing that can measure multiple components with one spectrum. Enhancements have been made to the compliant BWAnalyst software run on the touch-friendly embedded tablet computer. The newest software update follows an intuitive workflow and includes Raman shift calibration.

To learn more about the new QTRam updates, click here.

Equipment, Identification

AstraZeneca commits to at least 400 million doses of University of Oxford potential COVID-19 vaccine

After reaching a landmark agreement with the University of Oxford today for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2, AstraZeneca have now committed to at least 400 million doses. 

It is planned that the first shipments will begin rolling out to the U.K. in September, then the United States in October. The company does not intend to stop there, though. It has already secured a total manufacturing capacity for 1 billion doses of the vaccine and intends to engage further agreements that will expand global capacity over the coming months.

The effort has been supported by more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority (BARDA), which will be put toward development, production, and delivery of the vaccine beginning in the fall. Part of that process includes a 30,000 participant Phase III clinical trial, along with a pediatric trial. Phase 1 and 2 clinical trials to assess safety, immunogenicity, and efficacy in more than 1,000 healthy volunteers began last month. The next trials will be run in parallel with scaled manufacturing at BARDA’s Centers for Innovation and Advanced Development in Manufacturing.

 

Threat, Protection, Biological

DetectaChem to Launch COVID-19 Smartphone Testing Kit

DetectaChem, the world leader in innovative portable detection technologies, is preparing to launch a ground-breaking new COVID-19 (Coronavirus) testing solution utilizing automated smartphone detection and reporting. This solution enables actionable infection result data reports anytime, anywhere, and has been pre approved by the FDA for EUA

The test kits will utilize DetectaChem’s MobileDetect pouch technology, which allows a customer to use their own smartphone device to analyze a sample collected with the test kit, will provide lab validated detection results in 8 simpl steps, and deliver accurate results in 10-30 minutes.

Users will also be able to streamline communication with medical care providers for immediate instructions on how to proceed. This reporting function will also allow for proactive medical care information regarding incoming COVID-19 patient infections enabling proper allocation of life-saving equipment, such as ventilators in advance.

To find out more click here to vist DetectaChem's website.

Detection, Equipment, Identification, Biological

Kromek awarded up to $5.2m contract extension to develop device to identify pathogens by DARPA

Kromek, a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that it has been awarded an extension to its contract by the Defense Advanced Research Projects Agency (“DARPA”), an agency of the US Department of Defense, to detect and identify pathogens in an urban environment. This follows successful completion of the base period of the contract which was awarded by DARPA in December 2018 to develop a vehicle-mounted biological-threat identifier.

Under the terms of the new contract, Kromek has been awarded up to $5.2m to further work on its mobile wide-area bio-surveillance system capable of detecting airborne pathogens. The total contract period is up to June 2021. The completed system aims to extend the existing SIGMA network for biological threats as part of DARPA’s SIGMA+ initiative.

The miniaturised system will be capable of detecting viruses and bacteria and is intended to be located on vehicles to detect the presence of a pathogenic threat. The small, unmanned system that will run all day will also be capable of being used in high footfall areas, such as hospitals and airports.

Dr Arnab Basu, CEO of Kromek, said: “We are delighted to be awarded this extension by DARPA. The technology developed under this program is capable of sample collection to comprehensive analysis of threats present in air in an autonomous manner. By sequencing the genetic code, the device can not only identify threat pathogens, but also be used to identify the particular strain to aid triage and treatment selection, in addition to being able to track mutations of the pathogen.

“As the system can be vehicle mounted or placed in high footfall areas such as hospitals and airports, the location where the sample is collected can be mapped to a GPS position. The transfer of data to a central server allows a picture of pathogen levels across a city to be built up enabling decision makers to react rapidly to any evolving pathogenic threat.”

Threat, Identification, Biological

First EpiShuttle has landed in France

The isolation pod known as the EpiShuttle has finally reached France for evaluation from professional caretakers and medical transport. France is still comping with a large amount of corona patients and high rates of critical cases.

The EpiShuttle is already in service with The Royal Air Force in Scotland, The Royal Norwegian Air Force, the Royal Danish Air Force and the German Air Ambulance DRF.

Pandemics require highly complicated patient logistics. Safe transport of contagious patients may be essential in handling the epidemic, especially when it comes to critically ill patients. Patients must move safely across hospitals for treatment, between different hospitals for capacity and to hospitals for caretaking, without infecting others.

- The EpiShuttle enables safe transport of COVID-19 patients to where capacity is available. Healthcare workers are making an admirable effort transporting patients and at the same time putting their own heath on the line, but if we have to place everyone in quarantine, disinfect all helicopters, aircraft and ambulances after each transport, the whole system may collapse, Ellen Cathrine Andersen, CEO of EpiGuard says.

At EpiGuard, doctors and engineers have worked on solutions for transporting contagious patients for 5 years and have developed the EpiShuttle. The isolation stretcher ensures the safe transport of contagious patients and the safety of healthcare professionals. At the same time, the isolation stretcher allows critical treatment of the patient along the way.

- EpiGuard is currently experiencing a surge in demand for the EpiShuttle. The EpiShuttle is NATO stock listed and CE-marked as a class one medical device. We have increased production and are ready to deploy in France, Andersen says.

Facts about medical transfers of Covid-19 patients:

  • Wearing full personal protective equipment (PPE), causes fatigue and should not be performed for more than 2 hours.
  • Long distance evacuation of contagious patients requires several crews to rotate on performing necessary healthcare.
  • The airflow inside a helicopter can easily cause virus to flow from the patient to the crew.
  • The EpiShuttle allows crew to operate without wearing full personal protective equipment and without the need for a full disinfection of the ambulance or aircraft.

Equipment, Protection, Biological

The Cassandra Problem: Major General (ret.) Steve Reeves on being the CBRN voice in the wilderness

Watch any children’s adventure movie and you probably already know the plot.  Precocious adolescents discover a nefarious scheme, rush to tell the authorities, and are promptly ignored, dismissed and forgotten. It is now up to the young heroes to foil the scheme, dispatch the bad guys, and save the day.  In the closing scenes, the authorities tacitly admit their shortsightedness while publicly rewarding the brave children.  Finis. 

Like these child adventurers, in Greek Mythology Cassandra was given the gift of prophesy but cursed by Apollo to be ignored. Cassandra could foresee the calamity but would never be believed. 

CBRNE professionals can relate to Cassandra’s dilemma. In just the past two decades CBRNE professionals responded to: anthrax letters, SARS, H5N1 Bird Flu, Zika, Ebola, H1N1 Flu Pandemic, Fukushima Daiichi nuclear disaster, chemical weapons in the Middle East, and assassination attempts in London and Salisbury that resulted in death and expensive clean ups. In the wake of each of these, commissions were formed, well-respected experts testified before their political leaders, and thoughtful recommendations were provided. In a few instances, action followed including national stockpiles of medical supplies, improved processes, government organizational changes as well as numerous strategies and plans. For the most part, however, lessons learned rapidly became lessons observed.  Limited funding occasionally followed but other priorities eventually took precedent and the events of the past returned to remote, over-the-horizon concerns.   

As we deal with SARS-Cov-2 and Covid 19 the Cassandras are out in droves. Their mantra: “Woulda, Coulda, Shoulda” – the holy trinity of regret. If we would have listened, we could have been better prepared and responded sooner and our current situation should never have happened.  We now see the human toll, along with the political, social, economic, and national security consequences they predicted yet we failed to take their advice. 

In 2019 the U.S. Department of Health and Human Services conducted a simulation named "Crimson Contagion." The exercise included 19 federal agencies, U.S. states, tribal nations, hospitals and nongovernmental organizations. It simulated a severe influenza pandemic, originating in China, for which there is no vaccine. The draft report on the exercise identified limited US capacity to manufacture personal protective equipment, needles and syringes. It likewise stated that respirators and ventilators, and antiviral medication was largely produced overseas and would be difficult to restock.

Yet there’s really nothing new here. Since the 2001 anthrax letters attack, the US, its allies and academic institutions have conducted innumerable bioterrorism exercises.  One of the first such exercises was ”Dark Winter” sponsored by Johns Hopkins University.  It simulated an uncontrolled disease outbreak and the choices senior decision-makers must make.  The conclusions of the exercise will sound eerily familiar. “To end a disease outbreak after a bioterrorist attack, decision makers will require ongoing expert advice from senior public health and medical leaders.”  “The lack of sufficient vaccine or drugs to prevent the spread of disease severely limited management options.”The US health care system lacks the surge capacity to deal with mass casualties.” “Federal and state priorities may be unclear, differ, or conflict; authorities may be uncertain; and constitutional issues may arise.” “The individual actions of US citizens will be critical to ending the spread of contagious disease; leaders must gain the trust and sustained cooperation of the American people.” “There will be the rapid spread of misinformation on cures and treatments for the outbreak.”

With so many data and evidence-driven studies, reports and exercises, why is it then that these Cassandras were ignored? Both academics and practitioners come to similar conclusions. Christoph Meyer is a Professor at King’s College London, and Richard Clarke and R.P. Eddy are former members of the U.S. National Security Council. Both looked at warnings by contemporary Cassandra’s and come up with similar causative factors for why those warnings went unheeded. Factors that play into how receptive decision-makers are to warnings include politics, personal biases and characteristics and the perceived expertise of those giving the warning and their relationship to the decision-maker. The national bureaucracy also plays a role and may see any response to the warning as diverting resources from their own priorities. The frequent refrain is that it has never happened before, so why should we worry about it now. The timing of the warning may also play an outsized role, Professor Meyer anecdotally reported that the warning of an impending war was turned away because “There’s nothing on CNN yet.” There are underlying factors as well. As Clarke and Eddy point out, “Some decision makers are uncomfortable with the warning, in part because of its complexity and also because their lack of expertise may highlight their own inadequacies and make them dependent upon someone whose skills they cannot easily judge.” This isn’t helped by scientists’ reticence to make judgements with less than perfect data.  

Then there is the issue of priorities.  Where do pandemics or bioterrorism now fit among the myriad of competing Cassandras warning of dire consequences in areas ranging from domestic issues to foreign threats to the zombie apocalypse? Now that a pandemic is no longer a high risk, low probability, sometime, maybe event, what will be learned, what will adversaries learn, and how will governments respond?    

In the near term commissions will be formed, academic institutions will hold symposia and politicians with investigate. Some will make well-reasoned recommendations about systems, processes, organization and preparedness. Others will seek someone to blame, but will discover a multitude of small errors but no grand conspiracy. No doubt national medical stockpiles will soon be overwhelmed with masks, ventilators and other personal protective equipment.

What happens next is what will really matter.  Will the lessons of the pandemic be embedded in the national muscle-memory so nations are better prepared the next time, as Taiwan, Singapore and South Korea were due to the 2003 SARS outbreak? Will the costs of maintaining stockpiles be overtaken by other priorities and the stockpiles become relics, like so many tins of Civil Defense era biscuits and crackers? 

While this pandemic’s lessons may be forgotten, both state and non-state adversaries of democracy will learn important lessons from the pandemic. 9/11 amply demonstrated the value of asymmetric warfare against a superpower, and this history altering pandemic has exposed democracy’s vulnerabilities to a non-military approach to conflict. David Kilcullen is an Australian academic and military strategist. He labels this non-military approach a “conceptual envelopment,” stating “by the time we realize we are at war, we have already lost.”  He goes on to suggest that this approach is now used by both China and Russia but also observes that both state and non-state actors are increasingly resembling each other in their approach to confronting democracies. 

Fortunately there is also goodness to be found both in the pandemic’s lessons and the people responding.  There is the work of brilliant scientists using molecular techniques in virology.  Leveraging this understanding, vaccine development that typically takes eight or more years may be compressed to less than two years using vaccine platforms.  Manufacturers have demonstrated the ability to rapidly design and retool factories to produce ventilators as well as ramp up existing production facilities for critical items such as respirator masks.  There is also a new appreciation for public health officials and the now recognized everyday heroes who provide the basic needs of well-being and human survival in areas such as food, health, safety, transportation, and cleaning.  

Militaries will also change. Despite the frequent trope that generals always fight the last war, modern militaries are adaptive and learning organizations. As adversaries attempt to employ “conceptual envelopment,” land, sea and air defenses may become less important than cyber and space defenses. Cyber-attacks alone have the potential to disrupt the critical infrastructure of entire nations, including power, water, financial systems and supply chains. Space-based attacks could disrupt communications and all the systems that rely on them. The economic consequences of the pandemic will also ripple through national defense budgets resulting in reduced defense spending regardless of what political party is in charge. As a consequence, defense industries will continue to merge. Cost-shifting from defense departments to industry will also likely occur as national research and development budgets drop.  

Cassandras will always be out there and the question of which ones to listen to will be a challenge for national security professionals and politicians alike [More on this in Sean McFate’s New Rules of War, Ed.]. What is predictable is that volatility, complexity, ambiguity and uncertainty will be more the norm than the exception. Most nations will maintain a hedging strategy, attempting to balance competing priorities and security concerns and minimize risk in as many areas as possible.  What this means for CBRNE professionals is that in the near term, there may well be an increase in biodefense spending, but  it is unlikely that spending will be sustained. This will be a one thousand piece puzzle reading “some assembly required.” The safety and security of nations relies on government spending, even if “frugal innovation” becomes the watchword. Biological warfare is, after all, natures’ renewable threat.     

CBRNe

Introducing MRIGlobal's Mobile Mercury Lab

Beyond Mobile Labs: Introducing a New Lab that Transforms Mobility into Portability

Now more than ever, there is a call for mobile labs that can accommodate expansive operations within a small footprint without compromising quality or efficiency. 

The emergence of new technologies opened the door for handheld devices and tools, but until now, there hasn’t been a truly portable lab that enables people to reap the full benefits of those new devices at their point of need.

With the Mercury Lab, MRIGlobal has discovered a way to provide all the necessary logistics in a human-centered design that compresses into the size of a suitcase. This single-person-portable, grab-and-go case allows researchers from a variety of industries to take lab work anywhere. 

Get to know the Mercury Lab:
For more than three years, the team at MRIGlobal has worked diligently to perfect their portable lab. They started with an idea that transformed into a successful prototype, which will become the first commercially sold lab of its kind. 

The Mercury Lab provides everything needed to operate an efficient lab with a design construct similar to a standard laboratory workbench. Meant for single-person use, it folds into the size of a suitcase, meaning you can check it in as luggage on a plane or transport it in the back of a pickup truck. 

This makes the Mercury Lab great for a variety of applications such as food inspections, forensics and crime scenes, disaster response, and infectious disease diagnostics. With a lifetime that could last for several years, the Mercury Lab is a long-term unit with benefits that will continue to grow as technology expands. 

To find out more bout what the Mercury Lab can do for you click here

 

Equipment, CBRNe

Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute

Zeteo Biomedical LLC, Inc., a privately held, medical device company, in collaboration with the Nanovaccine Institute at Iowa State University, has been awarded a five year NIH grant to develop a room temperature stable, universal nasal flu vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx1™ Delivery Platform, along with technical services to support the development this nanoparticle DNA nasal flu vaccine. Zeteo’s ZEOx1™ Delivery Platform includes nasal delivery device configurations to support early stage, pre-clinical animal studies, human clinical trials and is commercially scalable to fill/finish and deliver millions of doses per day for global supply of nasal vaccines or medical countermeasures in the event of a pandemic crisis.

This development program is intended to address several major challenges with traditional flu vaccines in use today to protect the public. “We are focused on developing a broad spectrum flu vaccine to protect against multiple strains of both seasonal and pandemic flu viruses, and eliminate the requirement for refrigeration during storage and transport to reduce the cost. Our long-term vision is a universal nanoparticle nasal flu vaccine combined with Zeteo’s ZEOx1 Orion™ nasal delivery device technology that will facilitate both individual self-administration and caregiver administration. This approach will enable rapid deployment across large populations in both developed and developing nations in crisis conditions where the healthcare system may be overwhelmed or non-existent,” said Dr. Balaji Narasimhan, Director of the Nanovaccine Institute at Iowa State University.

Timothy Sullivan, President of Zeteo Biomedical, stated, “We look forward to the opportunity to work with the Nanovaccine Institute and our collaboration partners on this critically important biosecurity medical countermeasure to protect public health and the quality of human life.” The NIH grant will fund preliminary development and pre-clinical evaluation of this vaccine candidate through 2023. Mr. Sullivan is a Co-Principal Investigator on the project team.

About Zeteo Biomedical LLC
Zeteo Biomedical™ is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology and unit dose fill/finish packaging for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications. For more information please visit the Zeteo website at: https://www.zeteobiomed.com/

Protection, Biological, Technology, R&D

Suffolk County PD Doing it Right Thanks to Decade Old Training with LSU

From Newsday.com

Just 3.5% of Suffolk County’s 2,500 police officers have been infected with the coronavirus, Chief of Department Stuart Cameron said, due in large part to biohazard training the department developed a decade ago with experts at Louisiana State University.

Eighty-seven Suffolk police officers have tested positive for the virus, which Gov. Andrew M. Cuomo said on April 23 had potentially infected 16.7% of people on Long Island, citing an antibody study that found as many as 2.7 million state residents had been afflicted.

“I think these protocols have played a critical role in keeping the infection rate low, not only what we have done but also when we did it,” Cameron said. “You need to get ahead of this very early because once the infection takes hold in the department, it’s very, very difficult to mitigate it.” 

Thousands of first responders from agencies across the nation have been trained in protocols that began as pilot programs in Suffolk in 2009, according to Jason Krause, the associate director of operations and plans at Louisiana State’s National Center for Biomedical Research and Training Academy.

“Suffolk County played a very critical role in the development of bioawareness,” Krause said. 

About 15,000 police officers and other first responders across the nation have been trained in the protocols, Krause said, and the center has been flooded with inquiries from agencies since the coronavirus pandemic began. First responders in Europe, the Middle East and Southeast Asia have also received the training,  

Noel DiGerolamo, the president of the Suffolk Police Benevolent Association, praised Cameron for making sure members were properly trained and had adequate personal protective equipment nearly two months before the pandemic shut down much of the country. 

“Three-and-a-half percent is an astronomical achievement,” DiGerolamo said. 

Louisiana State, Krause said, is a member of the National Domestic Preparedness Consortium, a partnership between universities and federal labs that works with FEMA to train first responders on how to respond to terror attacks, explosions and other disasters. 

“Our specialty is biological weapons, accidental pathogen releases and natural pandemics,” Krause said. “How do you recognize you have a biological incident happening? How do you respond?”

Cameron, who had taken a three-day LSU training on biological threats about 15 years ago, asked the university’s experts to develop a curriculum to educate police officers, public health officials, firefighter, EMTs and other first responders on biohazards. 

Krause said the program took two years to develop. The cause of the disaster is less important than the strategy that comes next, he said. Topics covered by the protocols include the differences in responding to anthrax versus ricin attacks and the differences between toxins, bacteria and viruses. 

Perhaps most important, first responders are taught about the type of equipment they will need to protect themselves for each type of threat, and how to avoid infection by safely donning and doffing personal protective equipment. 

The protocols have been taught to recruits at the Suffolk police academy in Brentwood since 2014, and the department began creating refresher videos in late January that officers can view on the tablets in their patrol cars. One video, featuring Cameron, explains the differences between face coverings and how to properly handle them. LSU has also posted videos on its website intended to guide first responders through the pandemic.

Officers assume risks when they embark on careers in law enforcement, Cameron said, but their families do not. 

“That is one of the unique aspects of a biological threat,” Cameron said. “You can bring it home to your family ... rarely is there a law-enforcement threat that jeopardizes the safety of your family.”

Keeping the police healthy, Cameron added, keeps the whole community healthy. “If you don’t have police officers coming to work, you can’t operate the police department and you can’t keep the public safe,” he said.

Myanmar Police Seize SE Asia's Largest Ever Haul of Synthetic Drugs

Police in Myanmar have reportedly seized the largest ever haul of syntheitc drugs in South East Asia after a three month operation. 

The quantity, said to be 'off the charts' included more than 200m methamphetamine tablets, 500kg of crystal methamphetamine and 300kg of heroin, as well as more than 3,700 litres of methylfentanyl, a product used to make fentanyl. 

Thirty three people were arrested in connection with the drug operations. 

Myanmar is thought to be the largest global source of methamphetamine, so much so that the United Nations Office on Drugs and Crime (UNODC) has warned that this development suggests Southeast Asia is poised to become a significant source of synthetic drugs for other parts of the world. A new report from UNODC warns that the synthetic drug market in East and Southeast Asia continues to expand and diversify, and the price of methamphetamine has dropped to the lowest level in a decade as the supply has surged.

Released on May 15th, the report titled “Synthetic Drugs in East and Southeast Asia: Latest Developments and Challenges”, confirms that the variety and volume of synthetic drugs have increased in the past year. “It is hard to imagine that organized crime have again managed to expand the drug market, but they have”, remarked Jeremy Douglas, UNODC Representative for Southeast Asia and the Pacific. “While the world has shifted its attention to the COVID-19 pandemic, all indications are that production and trafficking of synthetic drugs and chemicals continue at record levels in the region.”  

 

Threat, Chemical

First Line Technology Announces AmbuBus QRT

First Line Technology (FLT), the manufacturer of the AmbuBus™ Conversion Kit that converts any school or metro bus into a multiple patient transport that can carry up to 24 patients, announces the release of the AmbuBus QRT Quick Response Transport (QRT)™. The AmbuBus QRT Conversion Kit™ is purpose-built for tactical military or law enforcement situations where a single ambulance is not enough and having multiple ambulances on a scene is not safe or practical.  

With only one AmbuBus QRT Conversion Kit, one person can convert an existing Sprinter style van into an ambulance capable of safely transporting six stretchers and IVs along with an operator and their medical support equipment.

The sturdy powder-coated structural steel frame of the QRT will easily fit into all 170-inch wheelbase Sprinters and Ford Transit Vans Two. This includes armored variants of these vehicles. Unlike ambulances which attract attention, the QRT appears to be a typical delivery vehicle for discrete medical transport in conflict areas.

It can also be used to transfer patients from nursing homes and hospitals due to the coronavirus (COVID-19).

The QRT™ comes in handy in other situations such as medical transport of homebound patients during natural disasters, active shooter incidents and small-scale medical evacuations.

The Ambu-QRT Conversion Kit weighs only 150 pounds but when assembled inside a vehicle can carry patients and medical equipment with a total weight of 2,000 pounds.

The adjustable frame of the QRT has a maximum assembled dimension of (LWH) 81.238” by 59.649” by 72.119”. The frame adjusts in two-inch increments to fit the dimensions of the preferred van. The frame is powdered coated structural steel and is manufactured entirely in the United States. The frame is magnetic for integration with portable medical accessories.

The AmbuBus QRT is compatible with the AmbuStretcher made by FLT as well as most standard and oversized NATO stretchers and backboards. The frame can stack one, two, or three patients on each side of the vehicle with room for the medic to triage and treat the patients. The individual stretcher heights can easily be adjusted by one person without using any tools.

The AmbuBus QRT is delivered in a stackable crate and once assembled, the frame can be folded and returned to the crate for easy storage,

According to Amit Kapoor, the President and CEO of First Line Technology, “The AmbuBus QRT was developed in direct response to our customers who needed a purpose-built vehicle to provide immediate medical care and transport to soldiers and law enforcement officers injured in the line of duty. We’re proud to be able to support those people who put their lives at risk to keep us safe.”

For more information on the AmbuBus QRT Conversion Kit and the other multiple patient transport solutions from First Line Technology visit https://www.firstlinetech.com/amburesponse/

Emergency, Equipment

Intelagard MACAWS for a CAUSE

Intelagard is giving away up to $75,000 in fire suppression and decontamination equipment to first responders. Dennis Smagac, President of Intelagard states: “As the global economy has been severely impacted by the Corona Virus, we at Intelagard want to give back to those organizations that have been and continue to be crucial to the safety of the community.

”Intelagard is giving away up to $75,000 in fire suppression and decontamination equipment to first responders. Dennis Smagac, President of Intelagard states: “As the global economy has been severely impacted by the Corona Virus, we at Intelagard want to give back to those organizations that have been and continue to be crucial to the safety of the community.”Intelagard will give away 12 Macaw Backpacks with 3-piece nozzle sets to fire departments, hazmat teams, hospitals, police departments and municipalities.

The Macaw backpack is a multi-purpose tool used for decontamination, fire suppression, exposure protections, hazardous material clean-up, and other safety services. It gives first responders the benefits of decreased exposure time and increased job completion in less time, increasing safety and saving on labor cost.

If you are a first responder working for a fire department, hazmat team, hospital, police department or municipality, simply fill out the contact form at www.intelagard.com and enter to win. Winners will be chosen at random.

Intelagard, Inc. is a privately held United States, Corporation, registered in Colorado. Intelagard provides a full range of innovative compressed air foam (CAF) dispersal equipment and foams for fire suppression, exposure protection, hazardous materials clean up, disinfection and decontamination of warfare agents. These products are sold to emergency response professionals, government agencies, militaries, remediation companies and industry.

Equipment, Decontamination

Our Current Partners